Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

In the latest trading session, Pfizer (PFE) closed at $27.63, marking a -0.32% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.57%. Elsewhere ...

Pfizer (NYSE:PFE) stock has remained depressed for an extended period and trades at an attractive forward price-earnings ...

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 70% based on the firm’s underlying fundamentals and the stock’s valuation.

Another one of the top long-term stocks to own, Pfizer (NYSE:PFE) has seen an unceremonious collapse in its share price. The ...

It is also worth noting that PFE currently has a PEG ratio of 1.26. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings ...

In an interview last month, Pfizer CEO Albert Bourla said that with a 6% yield, PFE stock “is almost like the best bond in ...

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 70% based on the firm’s underlying fundamentals and the stock’s valuation.